Study of Retinal Oxygenation in Central Retinal Vein Occlusion
NCT ID: NCT02523339
Last Updated: 2021-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
117 participants
OBSERVATIONAL
2014-10-31
2020-11-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measurement of Retinal Venous Pressure in Chronic Low-oxygen Environment
NCT01771770
Reflectometric Measurement of Retinal Oxygen Saturation in Patients With Chronic Obstructive Pulmonary Disease (COPD) Grade IV and Healthy Subjects
NCT00999024
Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and Oxymap
NCT02521116
Measurement of Retinal Blood Flow, Retinal Oxygenation and Retinal Oxygen Extraction in Healthy Subjects During Normoxia and Systemic Hyperoxia
NCT00914407
Age-related Changes in Retinal Oxygen Extraction in Healthy Subjects
NCT06643403
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent for participation.
* No treatment before the first oximetry measurement.
Exclusion Criteria
* Poor quality images will be excluded based on the images themselves. Therefore, grading of cataract or other media opacities is not strictly necessary for the purpose of the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Aston University
OTHER
University of Jena
OTHER
Medical University of Vienna
OTHER
University of Aarhus
OTHER
Clinical Research Center Memorial A. de Rothschild
UNKNOWN
Palacky University
OTHER
University of Toyama
OTHER
University of Iceland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sveinn Hakon Hardarson
Post-doctoral researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sveinn H. Hardarson, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Iceland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Clinical Pharmacology, Medical University of Vienna
Vienna, , Austria
Department of Ophthalmology, University Hospital and Faculty of Medicine and Dentistry, Palacky University Olomouc
Olomouc, , Czechia
Aarhus University. Department of Clinical Medicine - The Department of Ophthalmology
Aarhus, , Denmark
University Hospital Jena
Jena, , Germany
University of Iceland / Landspitali, Dept. of Ophthalmology
Reykjavik, , Iceland
Eye Clinic of the University Hospital Basel
Basel, Canton of Basel-City, Switzerland
Clinical Research Center Memorial A. de Rothschild
Geneva, , Switzerland
Aston University School of Life and Health Sciences
Birmingham, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UI-CRVO-2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.